NDC 55714-4581

Glaucoma

Aconitum Nap., Aur. Met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux Vom., Osmium Metallicum, Phosphorus, Physostigma, Rhus Toxicodendron, Spigelia Anth.

Glaucoma is a Oral Pellet in the Human Prescription Drug category. It is labeled and distributed by Newton Laboratories, Inc.. The primary component is Aconitum Napellus; Gold; Atropa Belladonna; Causticum; Cinchona Officinalis Bark; Colchicum Autumnale Bulb; Euphrasia Stricta; Gelsemium Sempervirens Root; Strychnos Nux-vomica Seed; Osmium; Phosphorus; Physostigma Venenosum Seed; Toxicodendron Pubescens Leaf; Spigelia Anthelmia.

Product ID55714-4581_f9b9f588-fd69-3ec2-1fd1-991ce8039491
NDC55714-4581
Product TypeHuman Prescription Drug
Proprietary NameGlaucoma
Generic NameAconitum Nap., Aur. Met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux Vom., Osmium Metallicum, Phosphorus, Physostigma, Rhus Toxicodendron, Spigelia Anth.
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2011-06-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameNewton Laboratories, Inc.
Substance NameACONITUM NAPELLUS; GOLD; ATROPA BELLADONNA; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; STRYCHNOS NUX-VOMICA SEED; OSMIUM; PHOSPHORUS; PHYSOSTIGMA VENENOSUM SEED; TOXICODENDRON PUBESCENS LEAF; SPIGELIA ANTHELMIA
Active Ingredient Strength15 [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g
Pharm ClassesStandardized Chemical Allergen [EPC],Increased Histamine Release [PE],Allergens [CS],Cell-mediated Immunity [PE],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Plant Proteins [CS],Seed Storage Proteins [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 55714-4581-1

28.35 g in 1 BOTTLE, GLASS (55714-4581-1)
Marketing Start Date2011-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55714-4581-1 [55714458101]

Glaucoma PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-06-01
Inactivation Date2020-01-31

NDC 55714-4581-2 [55714458102]

Glaucoma PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-06-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
ACONITUM NAPELLUS15 [hp_X]/g

OpenFDA Data

SPL SET ID:d2566f25-1d83-46eb-b136-8bc6e12f5098
Manufacturer
UNII

Pharmacological Class

  • Standardized Chemical Allergen [EPC]
  • Increased Histamine Release [PE]
  • Allergens [CS]
  • Cell-mediated Immunity [PE]
  • Non-Standardized Plant Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Allergens [CS]
  • Plant Proteins [CS]
  • Seed Storage Proteins [CS]

NDC Crossover Matching brand name "Glaucoma" or generic name "Aconitum Nap., Aur. Met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux Vom., Osmium Metallicum, Phosphorus, Physostigma, Rhus Toxicodendron, Spigelia Anth."

NDCBrand NameGeneric Name
55714-4580GlaucomaAconitum nap., Aur. met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux vom., Osmium metallicum, Phosphorus, Physostigma, Rhus toxicodendron, Spigelia anth.
55714-4581GlaucomaAconitum nap., Aur. met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux vom., Osmium metallicum, Phosphorus, Physostigma, Rhus toxicodendron, Spigelia anth.
68770-220Glaucomaarnica montana, gelsemium sempervirens, lycopodium clavatum, phosphorus, physostigma venenosum

Trademark Results [Glaucoma]

Mark Image

Registration | Serial
Company
Trademark
Application Date
GLAUCOMA
GLAUCOMA
73163222 1140329 Dead/Cancelled
AMERICAN SOCIETY OF CONTEMPORARYMEDICINE, SURGERY & OPTHALMOLOGY
1978-03-22

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.